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Diabetes mellitus is a major and rapidly growing public health
care problem. It is increasing in incidence, and brings with it long
term complications. Presently, more than 200 million people have
diabetes mellitus; by 2030, it is estimated that approximately 366
million will develop diabetes mellitus [1], and more than one third
of diabetes victims are unaware that they have this disease. Over
the last few decades, science and technology have dramatically
revolutionized living standards, providing a luxurious life with re-
mote control activities. Signiﬁcant changes have been observed in
the lifestyle of both the rural and urban population. Through this
modernization and change, people are eating more, and engage
in less physical activity; this contributes substantially to the devel-
opment of diabetes mellitus, and indeed, is fuelling an epidemic.
The ten countries estimated to have the highest number of people
with diabetes by 2030 are India, China, USA, Indonesia, Pakistan,
Brazil, Bangladesh, Japan, Philippines and Egypt [2]. In spite of
marvelous advancements in medicine, diabetes science and tech-
nology, diabetes mellitus remains an incurable, life-long disease.
It involves multiple systems, with wide ranging and devastating
complications, which may lead to severe disability, and is a prime
cause of excess morbidity and mortality. Among the major compli-
cations of diabetes mellitus are retinopathy with potential loss of
vision, nephropathy leading to renal failure, peripheral neuropathy
with risk of foot ulcers, amputations, and charcot joints, autonomic
neuropathy causing gastrointestinal, genitourinary, cardiovascular
symptoms and sexual dysfunction. Patients with diabetes have an
increased incidence of atherosclerotic cardiovascular, peripheral
arterial and cerebrovascular disease.
Not only does diabetes mellitus affect the health of a large pop-
ulation all over the world, but it gravely affects the world’s econ-
omy. Worldwide estimates suggest that the annual direct
medical cost of diabetes is at least US$ 129 billion, and may be
as high as US$ 241 billion, or 2.5–15.0% of global annual health1877-5934/ 2009 International Journal of Diabetes Mellitus. Published by Elsevier Ltd. O
doi:10.1016/j.ijdm.2009.03.007care budgets [3]. Moreover, almost three million people each year,
and about six people per minute, die worldwide due to the compli-
cations of diabetes mellitus [1]. Undeniably, diabetes mellitus is a
leading health and wealth risk all over the world. Therefore, the
sincere plea to the international health organizations and ofﬁcials
is that they should encourage further research in beta cell replace-
ment strategies, and human embryonic stem cells [4]. In addition
to enhancing research and the usual methods of treatment, inter-
vention in hospital programs by adopting physiological measures
and diabetes education support programs may also help to mini-
mize the burden of this devastating disease. Moreover, electronic
and print media sources should be fully utilized, in order to in-
crease the awareness of the risk factors of diabetes mellitus, to de-
velop understanding and control, and to promote better
management and health care policies in order to improve the qual-
ity of, and access to diabetes care.
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